Latest News
Dr. Reddy's launches first-to-market sugammadex injection in the US
4 August 2026 - Indian pharmaceutical company Dr. Reddy's Laboratories Ltd (BSE:500124, NSE:DRREDDY, NYSE:RDY) announced on Tuesday that it has launched Sugammadex Injection 200 mg/2 mL and 500 mg/5 mL single-dose vials in the United States as a...
Sanofi's MenQuadfi receives EU approval for infants from six weeks
4 August 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Tuesday that it has received European Commission approval to expand the EU indication for MenQuadfi (Meningococcal Group A, C, W and Y conjugate vacc...
Lilly secures FDA Breakthrough Therapy designation for olomorasib in pancreatic cancer
3 August 2026 - Medicine company Eli Lilly and Company (NYSE: LLY) announced on Monday that it has received U.S. Food and Drug Administration Breakthrough Therapy designation for olomorasib as a monotherapy for adults with previously treated advanced...
Acurx receives FDA guidance supporting ibezapolstat Phase 3 development strategy
3 August 2026 - Biopharmaceutical company Acurx Pharmaceuticals Inc (NASDAQ: ACXP) reported on Monday that it has received further FDA guidance on its ibezapolstat clinical development programme, including the potential for a single Phase 3 trial to ...
Genprex collaborates with Roche Diagnostics on NSCLC biomarker validation
3 August 2026 - Gene therapy company Genprex Inc (NASDAQ: GNPX) disclosed on Monday that it has entered into a collaboration with Roche Diagnostics to validate biomarkers for patient selection in non-small cell lung cancer (NSCLC) clinical trials, su...